Geroprotective and Anticarcinogenic Activity Lifetime Murine Studies Long-term studies in mice demonstrated that DSIP administration over a lifetime decreased total spontaneous tumour incidence 2.6-fold compared to untreated controls, slowed age-related switching-off of oestrous function, decreased the frequency of chromosome aberrations in bone marrow cells by 22.6%, and increased maximum lifespan by 24.1% compared to control groups a multi-parameter geroprotective profile that is among the most striking reported for any short regulatory peptide, and that has generated sustained interest in the DSIP analogue research field
Elamipretide: a review of its structure, mechanism of action, and therapeutic potential
Honeybee sting therapy is considered a classic therapeutic approach
Further, inhibition of ferroptosis alleviates the progression of liver diseases, such as nonalcoholic fatty liver disease (NAFLD), drug-induced liver injury (DILI), virus hepatitis, liver fibrosis, and hepatocellular carcinoma (HCC)
If LDL-C is at target (generally below 70 mg/dL for high-risk ASCVD patients per ACC/AHA 2019 guidelines), there is no phenotypic signal of interference
